ABSTRACT
TGF-13 receptors on the monocytes with a Kd of 1-10 pM. At higher concentrations of TGF-.3 (>1 ng/ml), monocytes are stimulated to generate biologically active mediator(s) that enhance fibroblast growth. Gene expression for one of these growth factors, interleukin 1, is induced in monocytes within hours after exposure to TGF-P. Thus, TGF-P may provide an important signal for monocyte recruitment and for regulation of their synthesis of mediators of fibroblast growth and activity in wound healing.
Transforming growth factor type P (TGF-P3) is a Mr 25, 000 peptide originally defined by its ability to induce phenotypic transformation of nonneoplastic cells in culture (1) . More recently, however, TGF-/3 has also been shown to be a product of hemopoietic cells, including platelets (2, 3) and lymphocytes (4) , and may play a role in wound healing (5, 6) . In this regard, the injection of 800 ng of TGF-f3 subcutaneously into newborn mice induced the rapid formation of granulation tissue similar to that which occurs in tissue repair (6) . The rapidity of these events and the deposition of collagen matrix suggested a direct effect on the recruitment of inflammatory cells and/or fibroblasts, although the mechanism of such a response is unknown. Other than fibroblasts, which are recruited by TGF-,p (7) , the cellular components of this granulation tissue that develops after subcutaneous injection of TGF-,B (6) (8) . The MNL were washed and suspended in Dulbecco's modified Eagle's medium (DMEM; Quality Biologicals, Gaithersburg, MD) containing 100 units of penicillin per ml, 100 gg of streptomycin per ml, and 2 mM glutamine. Total MNL, monocyte, and lymphocyte numbers were determined by Coulter Counter analysis (Coulter) and by nonspecific esterase staining. To obtain highly purified populations of lymphocytes and monocytes, the MNL were separated by counterflow centrifugal elutriation (CCE) and characterized by dual fluorescence microfluorometry (8, 9) . The CCEisolated population of monocytes consisted of >90% OKM1 bright cells expressing Fc receptors, Macl, HLA-DR, and receptors for the chemotactic ligands C5a and N-formylmethionylleucylphenylalanine (fMet-Leu-Phe) (9) . Lymphocyte preparations were consistently >95% OKT3 positive (8, 9) .
Monocyte Chemotaxis. MNL or CCE-purified monocytes were assayed routinely at 1 x 106 monocytes per ml in Gey's balanced salt solution (National Institutes of Health Media Unit) containing 2% bovine serum albumin, 100 units of penicillin per ml, 100 ,g of streptomycin per ml, and 0.015 M Hepes. The chemotaxis assay was carried out in 48-well microchamber plates (Neuroprobe, Rockville, MD) as described (9, 10) . The synthetic peptide fMet-Leu-Phe (Peninsula Laboratories, San Carlos, CA) (11) was a positive control and Gey's balanced salt solution was the negative control. TGF-P purified from human platelets and homogeneous by NaDodSO4/polyacrylamide gel analysis (2) 
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Fibroblast Proliferation. Primary guinea pig dermal fibroblasts (5 x 104 per ml) in DMEM supplemented with 50 ug of gentamicin per ml, 2 mM L-glutamine and 10% fetal calf serum were plated in 24-well polystyrene dishes (Costar, Cambridge, MA) (13, 14) . After 2-4 hr of adherence, the nonconfluent monolayers were washed free of serum, cultured overnight without serum, and then treated with monocyte supernatants. Monocyte supernatants were prepared by culturing CCE-purified adherent monocytes (1 x 106 monocytes per ml of DMEM) for 48 hr with TGF-03 (0-10 ng/ml).
The cell-free supernatants were diluted in DMEM and added to the fibroblast monolayers for 48 hr, after which 1.0 ,uCi of tritiated [3H]thymidine (specific activity, 6.7 Ci/mmol; 1 Ci = 37 GBq; Schwarz/Mann) was added to each well for 4 hr. Fibroblasts were trypsinized and harvested for determination of [3H]thymidine incorportation into DNA (14) .
RNA Blot Analysis. Total RNA was isolated from 2. MNL were isolated from peripheral blood, and lymphocyte or monocyte-enriched populations were separated by CCE as described (8) . MNL (*) or monocytes (o) (CCE-purified) were assayed for chemotactic activity at 1 x 106 monocytes per ml. Data are from a representastive experiment and chemotactic activity is defined as the mean (±SEM) number of monocytes that migrated through the filter pores in three standard fields for each of triplicate filters. fMet-Leu-Phe at 10 nM was a positive control (MNL = 142 ± 8) and Gey's balanced salt solution only, the negative control (MNL = 8 + 1). monocyte receptor expression for TGF-/3. Incubation of monocytes purified by CCE with increasing concentrations of biologically active '251-labeled TGF-P3 (12) demonstrated saturable binding for TGF-,3 (Fig. 2) . Scatchard analysis (Fig.   2 Inset) of the binding data showed a high-affinity binding site with a dissociation constant equal to 1-10 pM. Freshly isolated monocytes possess 400 binding sites per cell based on the total population, and the number of receptors decreases =50% with in vitro activation of the monocytes by lipopolysaccharide or y-interferon (data not shown).
TGF-.f Induction of Growth Factor Activity. The TGF-/3-induced accumulation of monocytes in vivo is accompanied by an increase in the local connective tissue fibroblast population (6) . Since TGF-p alone is usually not directly mitogenic when administered to fibroblast monolayers (20) , it was of interest to determine whether the expansion of the local fibroblast population might be indirectly mediated by the infiltrating monocyte population. The addition of TGF-,B to monocytes in culture resulted in the appearance of biologic activity in the monocyte supernatants, which stimulated fibroblast proliferation (Fig. 3) for other chemotactic peptides (19) . Although TGF-,3 could be functioning as a cofactor with a monocyte product to stimulate fibroblast replication in this assay, TGF-,f in combination with unstimulated monocyte supernatants was inactive (Fig. 3) , as was TGF-,p when added at equivalent concentrations to the fibroblast cultures directly.
TGF-f8-Induced Expression of IL-1p3 mRNA. Because stimulated monocytes have the capacity to secrete several molecules that have biologic activity in promoting fibroblast mitogenesis and that may act synergistically in the fibroblast proliferation assay, experiments were carried out to define whether TGF-/3 induced gene expression for IL-1, one of these well-defined growth factors. IL-1p3-specific mRNA, which is undetectable in resting monocytes, was substantially increased after 6 hr of exposure to TGF-f3 at 10 ng/ml ( TGF-P3 at picomolar concentrations can effectively regulate the transcription of IL-1, which is an effective regulator of fibroblast proliferation (21) . DISCUSSION TGF-13 is an extremely potent chemotactic ligand for human peripheral blood monocytes at concentrations ranging from 0.004 to 0.4 pM. This level of activity may make TGF-j3 the most potent known chemotactic substance for monocytes. The ability of monocytes to respond to femtomolar concentrations of a diffusing concentration gradient of TGF-f3 suggests a highly sensitive and selective mode of monocyte recruitment. Monocyte chemotaxis is dependent on the interaction of a chemotactic ligand with a specific cell-surface receptor (9, 19) as is evident by the identification of TGF-f3 receptors on freshly isolated peripheral blood monocytes.
The high-affinity receptor found on these cells is consistent with the low concentrations of TGF-P necessary to initiate a chemotactic response.
Following recruitment of monocytes, it appears that TGFp at higher concentrations can also activate monocytes to elaborate mitogenic monokines. Activated monocytes have the potential to generate numerous fibroblast growth-promoting factors (14) including IL-1, platelet-derived growth factor, fibroblast growth factor, and tumor necrosis factor (21) (22) (23) (24) (25) . Our data suggest that TGF-,B may provide an important induction signal to the monocytes for growth factor generation. Because of the complex interactions of the various monocyte growth factors and their dependence on cofactors for initiating* fibroblast growth in vitro (14), we focused on identifying potential TGF-f3-induced factors that regulate fibroplasia at the molecular level. Induction of monocyte mRNA for IL-1 by picomolar quantities of TGF-P indicates that gene expression of at least one fibroblast proliferation factor is inducible by TGF-P. In vivo, TGF-P has been shown to induce both fibrosis and angiogenesis (6) . Therefore, it will be of considerable interest to determine whether certain other growth factors that have recently been shown to be produced by monocytes, such as fibroblast growth factor, a potent inducer of angiogenesis (24, 26) , are also expressed by TGF-03-treated monocytes.
The findings that we are reporting here would appear to have functional significance in many situations in which macrophages participate in physiological or pathological processes offibrosis and angiogenesis. The process of normal wound healing, which involves both fibrosis and angiogenesis, is characterized by an ordered progression of inflammatory cells, beginning with platelets, followed by neutrophils, macrophages, and then lymphocytes (27) . It is known that subcutaneous injection of exogenous TGF-,B can elicit the same histological pattern of fibroblast accumulation and vascular growth that occurs when the above cells direct the normal wound healing process (6) . Based on the results of the present study, the chemotactic action of TGF-,B on macrophages may be a key phenomenon in tissue repair.
Thus, it is known that TGF-,1, in addition to platelet-derived growth factor (28) , is released from degranulating platelets at initial sites of tissue injury (29) , a process that could provide a simple mechanism for chemoattraction of monocytesmacrophages to a wound site. These macrophages in turn would appear to play a key role in the fibrogenic and angiogenic response that occurs at the wound site (14, 30) . Therefore, part of the wound healing action of TGF-13 in vivo may be indirect, mediated by the ability of TGF-P to attract monocytes and then to stimulate these monocytes to produce mitogenic and/or chemotactic substances that act directly on fibroblasts and capillary endothelium (27, 30) .
In addition to wound healing, the chemoattractant potency of TGF-f for macrophages may also be relevant for fibroblast proliferative diseases, which are characterized by fibrotic lesions. In this regard, it has been suggested that macrophages play an important role in driving the proliferative fibroblast response seen in diseases such as hepatic cirrhosis (31) or idiopathic pulmonary fibrosis (32) , and TGF-f3 may be involved in the initial recruitment, as well as in the activation, of the macrophages seen in these lesions. TGF-1 induced release of peptides such as IL-1 by monocytes may provide the growth signals responsible for fibroplasia and/or fibrogenesis characteristic of these diseases.
Another phenomenon relevant to the findings reported here is the presence of large numbers of macrophages in growing tumors. More than 20% of the total cells in certain tumors have been identified as macrophages (33) . Although the mechanisms of accumulation of these macrophages in the tumor are not known, the production of TGF-3 by many tumor cells (34) suggests that this peptide may play a significant role in recruiting macrophages into the tumor mass. Interestingly, it has also been suggested that these tumor-associated macrophages may enhance tumor growth by virtue of their ability to stimulate neovascularization (30, 35) . Our data would support this hypothesis since TGF-f3 appears to be a direct chemotactic signal for monocytes at extremely low concentrations and a powerful stimulator of potential angiogenic and fibrogenic factor production at higher concentrations, which may be present in the localized microenvironment of inflammation or tumor development.
